BMP Pharma Trading AG
XBER:BMP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.44
6.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| DE |
B
|
BMP Pharma Trading AG
XBER:BMP
|
27.8m EUR |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
972.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.5B USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
393.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
Market Distribution
| Min | -222 027.4% |
| 30th Percentile | -2% |
| Median | 2.2% |
| 70th Percentile | 6% |
| Max | 85 055.6% |
Other Profitability Ratios
BMP Pharma Trading AG
Glance View
B.M.P.Pharma Trading AG engages in the selling and distribution of pharmaceutical raw materials, dietary supplement products and raw materials of the veterinary industry. The company is headquartered in Norderstedt, Schleswig-Holstein. The company went IPO on 2004-04-21. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 3 years, BMP Pharma Trading AG’s Net Margin has increased from 5 266% to 85 055.6%. During this period, it reached a low of -1 892.3% on Jun 30, 2021 and a high of 85 055.6% on Jul 30, 2022.